logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Interaction Of Mycophenolic Acid And Pantoprazole A Pharmacokinetic Crossover Study 1st Edition Olesja Rissling Auth

  • SKU: BELL-6791912
Interaction Of Mycophenolic Acid And Pantoprazole A Pharmacokinetic Crossover Study 1st Edition Olesja Rissling Auth
$ 31.00 $ 45.00 (-31%)

4.8

64 reviews

Interaction Of Mycophenolic Acid And Pantoprazole A Pharmacokinetic Crossover Study 1st Edition Olesja Rissling Auth instant download after payment.

Publisher: Springer Spektrum
File Extension: PDF
File size: 8.94 MB
Pages: 177
Author: Olesja Rissling (auth.)
ISBN: 9783658198886, 9783658198893, 3658198885, 3658198893
Language: English
Year: 2017
Edition: 1

Product desciption

Interaction Of Mycophenolic Acid And Pantoprazole A Pharmacokinetic Crossover Study 1st Edition Olesja Rissling Auth by Olesja Rissling (auth.) 9783658198886, 9783658198893, 3658198885, 3658198893 instant download after payment.

Olesja Rissling analyzes the potential interaction of mycophenolic acid (MPA) and pantoprazole. MPA is used as an immunosuppressive drug to prevent acute organ rejections after organ transplantation. Pantoprazole, known to interact with the bioavailability of drugs, is used to prevent upper gastrointestinal disorders. The author performed a clinical pharmacokinetic study in renal transplant patients to evaluate a potential interaction of MPA and pantoprazole. The bioavailability and the maximum concentration of MPA were determined with or without pantoprazole intake. An influence on the immunosuppressive effect was evaluated by measuring the target enzyme activity. Overall, no significant change in the bioavailability or the maximum concentration was found. Similar results were obtained for the target enzyme activity after pantoprazole intake with MPA. The results suggest that the interaction of pantoprazole with MPA does not compromise the immunosuppressive effect to a clinically meaningful extent.

Related Products